Peripheral Artery Disease Market Projected to Deliver Greater Revenues By 2023

Market Research Future published a Half-Cooked research report on “Peripheral Artery Disease Market Research Report - Forecast to 2023”– Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023.

Peripheral Artery Disease Market Key players

Boston Scientific Corporation, KONINKLIJKE PHILIPS N.V, Abbott, Medtronic, B. Braun Melsungen AG, TERUMO CORPORATION, Becton, Dickinson and Company (BD), Sanofi S.A., Johnson Johnson Services, Inc., AstraZeneca Plc., Angioscore, Inc., Bristol-Myers Squibb Company, Betagenon AB, Proteon Therapeutics, Inc., Merck Co., Inc., Bayer HealthCare Pharmaceuticals, Symic Bio, Inc., CardioVascular BioTherapeutics, Inc., AnGes, Inc., TheraVasc Inc., Smith Nephew plc, Stryker Corporation, Cook Medical, Cordis, Aspen Surgical Products, Inc., Alcon Laboratories, Inc., Zimmer Biomet Holdings, Inc., and others are some of the prominent players at the forefront of competition in the peripheral artery disease market and are profiled in MRFR Analysis.

Peripheral Artery Disease Market - Overview

The peripheral artery disease market is growing mainly due to rising prevalence of arterial diseases. According to a recent study report published by the Market Research Future, the peripheral artery disease market is booming and expected to gain prominence over the forecast period. The market is forecast to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023).

Request Free Sample at https://www.marketresearchfuture.com/sample_request/1540

Peripheral artery disease, also known as peripheral vascular diseases or peripheral Occlusive diseases, is a narrowing of the peripheral arteries due to deposition of plaque or cholesterol on the walls of artery. The most common symptoms of the disease includes painful cramping in hip, thigh or calf muscles, coldness in lower leg or foot, Hair loss or slower hair growth, no pulse or a weak pulse in legs or feet, sores on toes, feet or legs, and erectile dysfunction in men. Peripheral artery disease is mostly caused by atherosclerosis in the peripheral arteries. In atherosclerosis, plaque becomes brittle, and triggers clot formation which further narrow the artery, or completely block it.

Notably, rising research and development expenditure is the primary driver for peripheral artery disease market. In the year of 2016, the RD expenditure in the Pharmaceutical Industry was EUR 35000 million, suggested by European Federation of Pharmaceutical Industries and Association. According to the Centres for Disease Control and Prevention, the per capita national health expenditures in 2015 was amounted to be USD 9,990 and total national health expenditure was USD 3.2 trillion. It is also reported that out of total national health expenditures in the US, prescription drugs 10.1% share.

Other push factors such as, rising prevalence of arterial diseases, and related complications, increasing awareness among the people, changing reimbursement policies, and growing geriatric population are also fuelling the growth of the market. As per the Pacific Bridge Medical, the government of China partially reimburses the cost of many drugs, provided the drug is in the list of China’s National Reimbursement Drug List (NRDL) which was first published in 2000. According to the Indian Brand Equity Foundation (IBEF), in 2016 the generics market of India stood at USD 26.1 billion.

Despite these drivers, presence of misbranded and spurious drugs, risk of infections, and side effects associated with treatment options are expected to hinder the growth of the market.

Peripheral Artery Disease Market - Competitive Analysis

The peripheral artery disease market is currently dominated by various players. Due to rising research and development expenditure various existing and new marketers are continuously coming up with advanced drugs to control this condition. The global peripheral artery disease market is currently dominated by numerous players.

Abbott is one of them by holding a strong share in the market. The company is a global leader that develops and manufactures pharmaceuticals and medical products. In 2017, the company entered into an agreement with Roxwood Medical for U.S. product distribution, and completed the acquisition of St. Jude Medical. In the year 2014, Abbott acquired Topera, Inc., a private, venture-backed medical device company to expand the catheter business. The significant strategies adopted by company is to merge with other market players to expand their portfolio in different business sectors, and to receive product clearance approval from government bodies.

Medtronic is another renowned market player in peripheral artery disease market. Medtronic is one of the world's largest standalone medical equipment development company. The company offers a distinct portfolio of products such as Euphora Semicompliant Balloon Dilatation Catheter, NC Euphora Noncompliant Balloon Dilatation Catheter, NC Sprinter RX/ OTW Noncompliant Balloon Dilatation Catheter, and others.

TABLE OF CONTENTS

1 INTRODUCTION

1.1 DEFINITION

1.2 SCOPE OF STUDY

1.2.1 RESEARCH OBJECTIVE

1.2.2 ASSUMPTIONS LIMITATIONS

1.2.2.1 ASSUMPTIONS

1.2.2.2 LIMITATIONS

1.3 MARKET STRUCTURE:

2 RESEARCH METHODOLOGY

2.1 RESEARCH PROCESS:

2.2 PRIMARY RESEARCH

2.3 SECONDARY RESEARCH:

3 MARKET DYNAMICS

3.1 DRIVERS

3.2 RESTRAINTS

3.3 OPPORTUNITIES

3.4 MACROECONOMIC INDICATORS

4 MARKET FACTOR ANALYSIS

4.1 PORTERS FIVE FORCES MODEL

4.2 BARGAINING POWER OF SUPPLIERS

4.3 BARGAINING POWER OF BUYERS

4.4 THREAT OF NEW ENTRANTS

4.5 THREAT OF SUBSTITUTES

4.6 INTENSITY OF RIVALRY

5. GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPES OF DEVICES

...Continued

Access Report Details @ https://www.marketresearchfuture.com/reports/peripheral-artery-disease-market-1540 

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

About This Author

Sapana Joined: March 13th, 2019